Compare LNTH & MRCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LNTH | MRCY |
|---|---|---|
| Founded | 1956 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 5.1B |
| IPO Year | 2014 | 1997 |
| Metric | LNTH | MRCY |
|---|---|---|
| Price | $79.49 | $77.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 7 |
| Target Price | ★ $83.20 | $80.00 |
| AVG Volume (30 Days) | ★ 1.0M | 431.7K |
| Earning Date | 05-25-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 72.69 |
| EPS | ★ 3.41 | N/A |
| Revenue | $343,374,000.00 | ★ $912,020,000.00 |
| Revenue This Year | N/A | $6.59 |
| Revenue Next Year | $13.47 | $9.56 |
| P/E Ratio | $23.56 | ★ N/A |
| Revenue Growth | 3.62 | ★ 9.19 |
| 52 Week Low | $47.27 | $39.89 |
| 52 Week High | $108.86 | $103.81 |
| Indicator | LNTH | MRCY |
|---|---|---|
| Relative Strength Index (RSI) | 60.94 | 37.31 |
| Support Level | $77.38 | $73.21 |
| Resistance Level | $83.53 | $79.27 |
| Average True Range (ATR) | 3.71 | 4.37 |
| MACD | 0.28 | -0.85 |
| Stochastic Oscillator | 60.42 | 1.40 |
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
Mercury Systems Inc is a commercial technology company serving the aerospace and defense industry. The company envisions, creates, and delivers secure open architecture solutions powering a broad range of mission-critical applications in challenging and demanding environments. Its Mercury Processing Platform spans the full breadth of signal processing from radio frequency front end to the human-machine interface to convert meaningful data, gathered in remote and hostile environments, into critical decisions. The company manufactures components, products, modules, and subsystems and sells to defense prime contractors, the U.S. government, original equipment manufacturers, and commercial aerospace companies. Geographically, it derives maximum revenue from the United States.